ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Circle Wolfspeed and AI Chip Names

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers turned aggressive this week. Wolfspeed now has 88.6% of its free float shorted, up nearly 5 percentage points over the past seven days. The semiconductor maker carries a 9.6-day cost to borrow. Its float is almost entirely absorbed by short positions, leaving little room for new bets.

Liquidia saw the biggest weekly jump among mid-caps. Short interest rose 8 percentage points to 26.6% of free float. Bearish pressure is growing fast in the pharma space.

Cerebras Systems, the AI chip company that went public recently, added 5.2 points to reach 20.1% short. Sceptics are building positions even as AI hardware remains a crowded long.

Grindr crept up to 19.4%, a 4.9-point rise on the week.

On the cost-to-borrow front, Donnelley Financial Solutions grabbed attention today. Its borrow rate surged 405% in one week to 0.85%, a sharp signal ahead of earnings.

Coursera drew two analyst downgrades in 48 hours. Short interest sits at 14.8% of free float, up 5.1% over the past week per ORTEX data included in today's news flow.

EverCommerce holds the highest short score among larger names at 97. Its 23-day cost to borrow stands at 91%, with availability of short shares at just 0.4%.

On the index radar, LXP Industrial Trust and CBIZ trade out of the Russell 2000 today following acquisition-driven deletions. Forced selling before 2 November may pressure both names.

Stocks in this article

How this article was generated

Generated
30 Oct 2026, 12:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.